Paper40909281
Mesenchymal stromal cells 2.0: thinking outside the box.
Mandl GA and 7 others. Front Immunol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Mesenchymal stromal cells 2.0: thinking outside the box. Papers, record 40909281. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40909281
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mesenchymal Stem Cells | Major topic |
| Antigen-Presenting Cells | Major topic |
| Animals | |
| Humans | |
| Mesenchymal Stem Cell Transplantation | |
| Neoplasms | |
| Cancer Vaccines | |
| Cell Differentiation | |
| Cellular Reprogramming |
Source PubMed
References93
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35563886 | The Molecular Mechanisms Governing the Assembly of the Immuno- and Thymoproteasomes in the Presence of Constitutive Proteasomes. | Cells | 2022 | https://conductscience.org/library/papers/35563886 | PubMed |
| 2 | 24872109 | Clinical use of dendritic cells for cancer therapy. | Lancet Oncol | 2014 | https://conductscience.org/library/papers/24872109 | PubMed |
| 3 | 16923606 | Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. | Cytotherapy | 2006 | https://conductscience.org/library/papers/16923606 | PubMed |
| 4 | 36394838 | Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial. | JAMA Oncol | 2023 | https://conductscience.org/library/papers/36394838 | PubMed |
| 5 | 35492876 | Promoting antigen escape from dendritic cell endosomes potentiates anti-tumoral immunity. | Cell Rep Med | 2022 | https://conductscience.org/library/papers/35492876 | PubMed |
| 6 | 26907999 | Lipid peroxidation causes endosomal antigen release for cross-presentation. | Sci Rep | 2016 | https://conductscience.org/library/papers/26907999 | PubMed |
| 7 | 33923887 | Role of Proteasomes in Inflammation. | J Clin Med | 2021 | https://conductscience.org/library/papers/33923887 | PubMed |
| 8 | 5654088 | Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. | Transplantation | 1968 | https://conductscience.org/library/papers/5654088 | PubMed |
| 9 | 21412238 | Human immunology: a case for the ascent of non-furry immunology. | Immunol Cell Biol | 2011 | https://conductscience.org/library/papers/21412238 | PubMed |
| 10 | 37254712 | Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell. | Adv Sci (Weinh) | 2023 | https://conductscience.org/library/papers/37254712 | PubMed |
| 11 | 19654411 | Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties. | Blood | 2009 | https://conductscience.org/library/papers/19654411 | PubMed |
| 12 | 24566916 | Regulation of immune responses by extracellular vesicles. | Nat Rev Immunol | 2014 | https://conductscience.org/library/papers/24566916 | PubMed |
| 13 | 30104634 | The immunoproteasome and thymoproteasome: functions, evolution and human disease. | Nat Immunol | 2018 | https://conductscience.org/library/papers/30104634 | PubMed |
| 14 | 17540904 | Regulation of CD8+ T cell development by thymus-specific proteasomes. | Science | 2007 | https://conductscience.org/library/papers/17540904 | PubMed |
| 15 | 15340416 | Cancer immunotherapy: moving beyond current vaccines. | Nat Med | 2004 | https://conductscience.org/library/papers/15340416 | PubMed |
| 16 | 31730279 | Immune modulation by mesenchymal stem cells. | Cell Prolif | 2020 | https://conductscience.org/library/papers/31730279 | PubMed |
| 17 | 40060894 | Forced intracellular degradation of xenoantigens as a modality for cell-based cancer immunotherapy. | iScience | 2025 | https://conductscience.org/library/papers/40060894 | PubMed |
| 18 | 35744930 | Accum™ Technology: A Novel Conjugable Primer for Onco-Immunotherapy. | Molecules | 2022 | https://conductscience.org/library/papers/35744930 | PubMed |
| 19 | 16493000 | Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. | Blood | 2006 | https://conductscience.org/library/papers/16493000 | PubMed |
| 20 | 15522656 | Part I: Vaccines for solid tumours. | Lancet Oncol | 2004 | https://conductscience.org/library/papers/15522656 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42840442 | Mesenchymal stromal cells and paracrine modulation of neuroplasticity in the central nervous system. | EXCLI J | 2026 | https://conductscience.org/library/papers/42840442 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40909281
GET https://conductscience.org/api/papers/v1/40909281/references?page=2